Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new page revision label (v3.7.0) is added to the record history, replacing the previous v3.6.6 label. This reflects a minor update to the revision metadata of the study page.
    Difference
    0.1%
    Check dated 2026-09-19T18:21:58.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The record history now includes a new Revision: v3.6.6 entry, and the previous Revision: v3.6.5 entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-29T18:18:10.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Newest history entry shows Revision: v3.6.5 in the version list. This change is a small metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-08-15T10:56:14.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    New revision entry added: v3.6.4 replaces v3.6.3 in the history. This reflects an update to the record's version history without changing content or study details.
    Difference
    0.1%
    Check dated 2026-07-25T05:15:57.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The revision history now lists the latest revision as v3.6.3, replacing the previous v3.6.2. This reflects an update to the version trail in the study record history.
    Difference
    0.1%
    Check dated 2026-07-03T20:48:43.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The record history shows a new revision entry, updating from v3.6.0 to v3.6.2 to reflect a software version change on the page.
    Difference
    0.1%
    Check dated 2026-06-27T00:31:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.